These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10559628)

  • 21. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer.
    Barry MJ; Fowler FJ; Bin L; Oesterling JE
    J Urol; 1997 Aug; 158(2):488-91; discussion 492. PubMed ID: 9224330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benign prostatic hyperplasia (BPH) management in the primary care setting.
    Kapoor A
    Can J Urol; 2012 Oct; 19 Suppl 1():10-7. PubMed ID: 23089343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Variation in the diagnosis and treatment of benign prostatic hyperplasia in urological practice].
    Stoevelaar HJ; van de Beek C; Casparie AF; Nijs HG; McDonnell J; Janknegt RA
    Ned Tijdschr Geneeskd; 1996 Apr; 140(15):837-42. PubMed ID: 8668278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
    Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
    Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
    Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
    Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative randomized study on the efficaciousness of treatment of BOO due to BPH in patients with prostate up to 100 gr by endoscopic gyrus prostate resection versus open prostatectomy. Preliminary data.
    Giulianelli R; Brunori S; Gentile BC; Vincenti G; Nardoni S; Pisanti F; Shestani T; Mavilla L; Albanesi L; Attisani F; Mirabile G; Schettini M
    Arch Ital Urol Androl; 2011 Jun; 83(2):88-94. PubMed ID: 21826881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urologists' attitudes to sexual complications of LUTS/BPH treatments.
    Giona S; Ganguly I; Muir G
    World J Urol; 2018 Sep; 36(9):1449-1453. PubMed ID: 29680951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practice patterns regarding prostate cancer and benign prostatic hyperplasia in Japanese primary care practitioners.
    Fukagai T; Maruyama K; Nagata M; Morita M; Naoe M; Yoshida H
    Int J Urol; 2007 May; 14(5):412-5. PubMed ID: 17511723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia.
    Lowe FC; McDaniel RL; Chmiel JJ; Hillman AL
    Urology; 1995 Oct; 46(4):477-83. PubMed ID: 7571214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outline of JUA clinical guidelines for benign prostatic hyperplasia.
    Homma Y; Gotoh M; Yokoyama O; Masumori N; Kawauchi A; Yamanishi T; Ishizuka O; Seki N; Kamoto T; Nagai A; Ozono S;
    Int J Urol; 2011 Nov; 18(11):741-56. PubMed ID: 22050351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimally invasive therapy for benign prostatic hyperplasia: practice patterns in Minnesota.
    Ercole B; Lee C; Best S; Fallon E; Skenazy J; Monga M
    J Endourol; 2005 Mar; 19(2):159-62. PubMed ID: 15798410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians.
    Collins MM; Barry MJ; Bin L; Roberts RG; Oesterling JE; Fowler FJ
    J Gen Intern Med; 1997 Apr; 12(4):224-9. PubMed ID: 9127226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic and therapeutic management of the benign prostatic hyperplasia by the general practitioners in the Maine-et-Loire].
    Bigot P; Vannier F; Orsat M; Lebdai S; Huez JF; Fanello S; Azzouzi AR
    Prog Urol; 2010 Jan; 20(1):65-70. PubMed ID: 20123530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canadian guidelines for the management of benign prostatic hyperplasia.
    Nickel JC; Herschorn S; Corcos J; Donnelly B; Drover D; Elhilali M; Goldenberg L; Grantmyre J; Laroche B; Norman R; Piercy B; Psooy K; Steinhoff G; Trachtenberg J; Saad F; Tanguay S; ;
    Can J Urol; 2005 Jun; 12(3):2677-83. PubMed ID: 16011814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO; Théret N; Taïeb C;
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [How to evaluate BPH-related SBAUs in clinical practice and research?].
    Descazeaud A; Robert G; de La Taille A
    Prog Urol; 2018 Nov; 28(15):830-838. PubMed ID: 30220536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.